Adenovirus technology for gene manipulation and functional studies

Yibin Wang, Shuang Huang

Research output: Contribution to journalReview article

43 Citations (Scopus)

Abstract

Recombinant adenoviral vectors are highly efficient at gene transfer in a broad spectrum of cell types and species, and have been used, both in vitro and in vivo, to achieve gain or loss of function in functional studies. In recent years, there have been several significant advances in adenovirus technologies, including new generations of vectors, improved production systems and sophisticated methods of delivery. In this review, recent progress and innovative applications are discussed to demonstrate the potential of the recombinant adenoviral vector as an effective tool in functional genomics.

Original languageEnglish (US)
Pages (from-to)10-16
Number of pages7
JournalDrug Discovery Today
Volume5
Issue number1
DOIs
StatePublished - Jan 1 2000

Fingerprint

Genomics
Adenoviridae
Technology
Genes
In Vitro Techniques

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Adenovirus technology for gene manipulation and functional studies. / Wang, Yibin; Huang, Shuang.

In: Drug Discovery Today, Vol. 5, No. 1, 01.01.2000, p. 10-16.

Research output: Contribution to journalReview article

Wang, Yibin ; Huang, Shuang. / Adenovirus technology for gene manipulation and functional studies. In: Drug Discovery Today. 2000 ; Vol. 5, No. 1. pp. 10-16.
@article{b46e2f1f7cfc4ab9b3d14106fd618893,
title = "Adenovirus technology for gene manipulation and functional studies",
abstract = "Recombinant adenoviral vectors are highly efficient at gene transfer in a broad spectrum of cell types and species, and have been used, both in vitro and in vivo, to achieve gain or loss of function in functional studies. In recent years, there have been several significant advances in adenovirus technologies, including new generations of vectors, improved production systems and sophisticated methods of delivery. In this review, recent progress and innovative applications are discussed to demonstrate the potential of the recombinant adenoviral vector as an effective tool in functional genomics.",
author = "Yibin Wang and Shuang Huang",
year = "2000",
month = "1",
day = "1",
doi = "10.1016/S1359-6446(99)01433-6",
language = "English (US)",
volume = "5",
pages = "10--16",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Adenovirus technology for gene manipulation and functional studies

AU - Wang, Yibin

AU - Huang, Shuang

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Recombinant adenoviral vectors are highly efficient at gene transfer in a broad spectrum of cell types and species, and have been used, both in vitro and in vivo, to achieve gain or loss of function in functional studies. In recent years, there have been several significant advances in adenovirus technologies, including new generations of vectors, improved production systems and sophisticated methods of delivery. In this review, recent progress and innovative applications are discussed to demonstrate the potential of the recombinant adenoviral vector as an effective tool in functional genomics.

AB - Recombinant adenoviral vectors are highly efficient at gene transfer in a broad spectrum of cell types and species, and have been used, both in vitro and in vivo, to achieve gain or loss of function in functional studies. In recent years, there have been several significant advances in adenovirus technologies, including new generations of vectors, improved production systems and sophisticated methods of delivery. In this review, recent progress and innovative applications are discussed to demonstrate the potential of the recombinant adenoviral vector as an effective tool in functional genomics.

UR - http://www.scopus.com/inward/record.url?scp=0033972765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033972765&partnerID=8YFLogxK

U2 - 10.1016/S1359-6446(99)01433-6

DO - 10.1016/S1359-6446(99)01433-6

M3 - Review article

VL - 5

SP - 10

EP - 16

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 1

ER -